Alzheimer's Science and Progress

Research only
All of alz.org

Text Size

A future without Alzheimer's

The race is on. Alzheimer research is a dynamic field, and momentum builds each year. This site is for professional researchers and anyone interested in following the progress in research. The Alzheimer's Association has been involved in every major advancement in Alzheimer research since the 1980's and is a leader in the global fight for a world without Alzheimer's.

what we know today		tomorrow's answers		clinical trials
	About Alzheimer's disease Changes inside the brain Causes Current drug treatments		Drug treatment pipeline Earlier diagnosis Prevention Our funding strategy		Find a trial Why participate How trials work TrialMatch

Research Updates

spotlight

September 1, 2010 Study in Mice Hints Cancer Drug May Offer a New Strategy to Stop Beta-amyloid Production Finding Suggests a New Aim for Alzheimer's Drugs - New York Times

August 17, 2010 Phase III of Semagacestat Trial Halted Lilly Halts Alzheimer’s Drug Trial - New York Times Statement Regarding Lilly Halting Dosing in Phase III Alzheimer’s Disease Drug Trial of Semagacestat - Alzheimer's Association

August 11, 2010 New Study Shows Promise of Biomarker for Early Diagnosis Spinal Fluid Test a New Tool for Diagnosing Alzheimer's Disease - PBS NewsHour Statement Regarding ADNI Biomarkers Article from Archives of Neurology - Alzheimer's Association Abstract: Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People - Archives of Neurology

July 2010 News from AAICAD "Hot Topics" from the Alzheimer's Association International Conference on Alzheimer's Disease 2010 Early Detection, Diagnosis & Care Management for People with Dementia May Reduce Healthcare Costs New Research Advances from the Alzheimer's Association International Conference on Alzheimer's Disease 2010 National Institute on Aging and Alzheimer's Association Lead Effort to Update Diagnostic Criteria for Alzheimer's Disease

ALL UPDATES

	Alzheimer's Breakthrough Ride™
Researchers are riding from coast to capital to raise awareness.
	Funding and grant opportunities
We help researchers in every stage of their career.
	NEW TrialMatch™
This free service helps connect people with clinical trials.
	World Wide ADNI
World Wide Alzheimer's Disease Neuroimaging Initiative

you can help

Alzheimer's & Dementia Journal

Current Issue | Sept. 2010 | Vol. 6, No. 5

ABOUT THE JOURNAL

Key awareness milestones

Key events during the past 100 years spurred public awareness of Alzheimer's disease and ignited a massive research effort to learn more.

See more milestones

Our research strategy

The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest private, nonprofit funder of Alzheimer research. We believe in the value of collaboration and are willing to imagine a time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.

We fund — We have awarded in excess of $265 million to more than 1,800 projects over the life of our grants program.
We connect and convene — We provide global forums to advance the field through our international conference, our scientific journal and our professional society.
We collaborate — We find common ground and partner with our colleagues in government, academia, industry and other nonprofit organizations.
We advocate — We work to ensure that our policy and publicly funded research initiatives reflect the importance of Alzheimer's disease as a national health priority.
We seize opportunities — We remain flexible and nimble to identify issues, respond to evolving science and fill gaps.

More about the Alzheimer's Association commitment to research.